http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2020006344-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bce8e143c59bc79dddac8bb94e32836e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2018-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85f74718094202556ea179099b42f391
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bdc5fbea014880d5f6b99ebf1b2a483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f1dbed9e218f029877b5683c2c47df7
publicationDate 2020-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2020006344-A
titleOfInvention USE OF CELIPROLOL TO TREAT VASCULAR EHLERS-DANLOS SYNDROME IN WOMEN DURING PREGNANCY AND THE PERIPARTUM PERIOD.
abstract The present disclosure relates to the use of celiprolol or a pharmaceutically acceptable salt thereof to treat vascular Ehlers-Danlos syndrome in women during pregnancy and the peripartum period.
priorityDate 2017-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2663

Total number of triples: 20.